Pacelliallee 4
36043 Fulda
Phone:
0661-84-0
Fax:
0661-84-5013
Mail:
ed.adluf-mukinilk@ofni
Bezeichnung | |
Teilnahme externe Qualitätssicherung | yes |
Bezeichnung | |
Teilnahme externe Qualitätssicherung | yes |
Bezeichnung | |
Teilnahme externe Qualitätssicherung | yes |
Quantity performed | 19 |
Exception? | No exception |
Quantity performed | 57 |
Exception? | No exception |
Quantity performed | 24 |
Exception? | No exception |
Quantity performed | 15 |
Exception? | No exception |
Quantity performed | 32 |
Exception? | No exception |
Overall result forecast presentation: | yes |
Quantity performed reporting year: | 57 |
Quantity forecast year: | 74 |
Examination by state associations? | yes |
Exemption? | no |
Result of the examination by the federal state authorities? | no |
Transitional arrangement? | no |
Overall result forecast presentation: | yes |
Quantity performed reporting year: | 24 |
Quantity forecast year: | 19 |
Examination by state associations? | yes |
Exemption? | no |
Result of the examination by the federal state authorities? | no |
Transitional arrangement? | no |
Overall result forecast presentation: | yes |
Quantity performed reporting year: | 32 |
Quantity forecast year: | 26 |
Examination by state associations? | yes |
Exemption? | no |
Result of the examination by the federal state authorities? | no |
Transitional arrangement? | no |
Overall result forecast presentation: | yes |
Quantity performed reporting year: | 15 |
Quantity forecast year: | 13 |
Examination by state associations? | yes |
Exemption? | no |
Result of the examination by the federal state authorities? | no |
Transitional arrangement? | no |
Overall result forecast presentation: | yes |
Quantity performed reporting year: | 19 |
Quantity forecast year: | 16 |
Examination by state associations? | yes |
Exemption? | no |
Result of the examination by the federal state authorities? | no |
Transitional arrangement? | no |
No. | Explanation |
---|---|
CQ18 | Measures for quality assurance of positron emission tomography in patients with Hodgkin lymphoma and aggressive non-Hodgkin lymphoma for interim staging after chemotherapy to decide on the continuation of therapy (Amended by resolution of July 15, 2021, see CQ29). |
CQ25 | Measures for quality assurance in the performance of minimally invasive heart valve interventions pursuant to Article 136, para. 1, sentence 1, number 2 for hospitals licensed in accordance with Article 108 of the SGB V |
CQ30 | Quality assurance guideline for interstitial LDR brachytherapy for low-risk localized prostate cancer (effective January 8, 2021). |
CQ05 | Measures for quality assurance in the care of pre-term and full-term neonates – Perinatal Centre LEVEL 1 |
CQ22 | Quality assurance measures for interstitial low-dose-rate brachytherapy for the treatment of localised prostate cancer (These QA measures will expire at the end of January 7, 2021). |
CQ03 | Quality assurance measures for the implementation of positron emission tomography (PET) in hospitals for the indications non-small-cell lung cancer (NSCLC) and solid pulmonary nodules |
CQ01 | Quality assurance measures for inpatient care with the indication abdominal aortic aneurysm |
CQ27 | Guideline on quality assurance measures for inpatient care with bronchoscopic lung volume reduction procedures for severe emphysema (QS Guideline bronchoscopic LVR /QS-RL BLVR) |
CQ28 | Guideline on quality assurance measures for liposuction procedures for stage III lipedema (QS-RL Liposuction) |
Number | Group |
---|---|
251 | Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training* |
239 | Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence |
198 | Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations |
Training of employees on AMTS related topics
Availability of appropriate, topic-specific informational materials for patients on AMTS e.g. for chronic diseases, for high-risk drugs, for children
Apotheken Handbuch
31.12.2020
Electronic support for the admission and anamnesis process (e.g. import of patient master data or medication plans, use of a drug knowledge database, input screen for drugs or anamnesis information)
Zentrales QM Handbuch
31.12.2020
Possibility of electronic prescription i.e. structured entry of active substances (or name of the preparation), form, dose, dose frequency (e.g. in the HIS, in prescription software)
Provision of one or more electronic drug information systems (e.g. Lauer-Taxe®, ifap klinikCenter®, Gelbe Liste®, Fachinfo-Service®)
Electronic documentation of the administration of drugs
Universitätsmedizin Marburg - Campus Fulda ; Universitäre Lehre Humanmedizin: 2. und 3. klinisches Studienjahr ( 7.-10. Semester) und Praktisches Jahr
FL08 - Editors of scientific journals/textbooks
FL06 - Participation in multi-centre phase III/IV studies
FL07 - Initiation and management of uni-centric/multi-centric clinical/scientific studies
FL01 - Lectureships / teaching posts at colleges and universities
FL05 - Participation in multi-centre Phase I/II studies
FL09 - Doctoral supervision
FL02 - Lectureships / teaching posts at universities of applied sciences
FL04 - Project-related cooperation with colleges and universities
HB19 - Nursing professionals
HB05 - Medical technical radiology assistant (MTRA) (m/f)
HB07 - Surgical technical assistant (m/f)
HB12 - Medical technical laboratory assistant (MTLA) (m/f)
HB15 - Anaesthesia technical assistant (m/f)
Praktischer Teil
HB17 - Auxiliary nurse (m/f)
Mathilde Purtauf
Patientenfürsprecherin
Pacelliallee 4
36043 Fulda
Phone: 0661-84-6652
Mail: ed.adluf-mukinilk@ofni
Leo Zehkorn (ab November 2021)
Patientenfürsprecher
Pacelliallee 4
36043 Fulda
Phone: 0661-84-6652
Mail: ed.adluf-mukinilk@ofni
Assessorin Bärbel Schwalm
Leiterin Stabsstelle Recht und Compliance
Pacelliallee 4
36043 Fulda
Phone: 0661-84-5130
Mail: ed.adluf-mukinilk@mlawhcs.lebreab
Boris Krah
Leiter Qualitäts- und Risikomanagement
Pacelliallee 4
36043 Fulda
Phone: 0661-84-5131
Mail: ed.adluf-mukinilk@hark.sirob
Heil Stefanie
Leiterin Qualitäts- und Risikomanagement (kommissarisch)
Pacelliallee 4
36043 Fulda
Phone: 0661-84-5131
Mail: ed.adluf-mukinilk@lieh.einafets
Prof. Dr. Roland Radziwill
Direktor Apotheke
Pacelliallee 4
36043 Fulda
Phone: 0661-84-6430
Mail: ed.adluf-mukinilk@lliwizdaR.dnaloR
Mathilde Purtauf
Patientenfürsprecherin
Pacelliallee 4
36043 Fulda
Phone: 0661-84-6652
Mail: ed.adluf-mukinilk@ofni
Ronald Petrovic-Poljak
Pflegedirektor
Pacelliallee 4
36043 Fulda
Phone: 0661-84-5023
Mail: ed.adluf-mukinilk@LDP
Burkhard Bingel
Vorstand Administration
Pacelliallee 4
36043 Fulda
Phone: 0661-84-5017
Mail: ed.adluf-mukinilk@ofni
Priv. Doz. Dr. med. Thomas P. Menzel
Vorstand Krankenversorgung (Vorstandssprecher)
Pacelliallee 4
36043 Fulda
Phone: 0661-84-5011
Mail: ed.adluf-mukinilk@ofni
Priv.-Doz. Dr. med. Thomas Menzel
Vorstand Krankenversorgung
Pacelliallee 4
36043 Fulda
Phone: 0661-84-5011
Mail: ed.adluf-mukinilk@ofni
IK: 260620157
Location number: 772145000
Old location number: 772145000